Objective To summarize the imaging findings of intracranial central nervous system(CNS)malformations children in the high-altitude plateau(Xigaze city).Methods We retrospectively reviewed the imaging data of the suspected patients having CNS malformations,which enrolled either by the clinic or by the ultrasound in the Shigatse People's hospital from June,2019 to June,2023.All imaging data were interpreted by two experienced radiologists with consensus reading.Imaging characteristics were recorded roughly by primary/secondary,supra-/subtentorial malformation type and the corresponding clinical symptoms.Results A total of 36 children were included in this study,including 19 patients≤1 year old(including 2 newborns),7 patients between 1 and 3 years old,and 10 patients>3 years old.Seven cases underwent MRI examination,others having CT scan.Polygyria and pachygyria malformation were the most common type of congenital neurological malformations(7 cases,31.8%),followed by cystic changes of the cerebral parenchyma(3 cases,13.6%).Cerebral atrophy was the most common type of secondary CNS abnormalities group(8 cases,57.1%),followed by communicative hydrocephalus(3 cases,21.4%).Five patients in the congenital group and 4 patients in the secondary CNS group had the complex malformations.There were 8 dead cases(all in the≤1-year-old group),12 cases having neurological sequelae,1 case with normal development and 15 cases with loss of follow-up.There were no significant differences between primary and secondary CNS group regarding the final outcome.Conclusion In this study,gyrus developmental malformation and encephalatrophy were the most common etiologies in infants'CNS malformations.Reasonable use of imaging modalities will help depict the complicated CNS malformations and design individual treatment.

Objective To explore the effect of sorafenib on HeLa cell proliferation by inducing cell apoptosis and autophagy and its impact on drug resistance.Methods The drug-resistant cell strains were constructed through in-termittent induction method,with concentrations of 0,2.5,5.0,7.5,10.0,15.0,20.0 μmol/L.HeLa cells were incubated with increasing concentrations of sorafenib with each concentration for 1 week.The drug-resistant cell strains with stable passages were collected.MTT assay was used to detect the effect of sorafenib on cell prolifer-ation.Cell cycle distribution was analyzed by flow cytometry.The change in the expression of drug-resistant and ap-optotic genes in the parents and drug-resistant cell strains under different drug concentrations was examined by semi-quantitative PCR.The changes of apoptotic related marker proteins LC3-Ⅰ and LC3-Ⅱ were detected by Westernblot.Results Stable drug-resistant strains were successfully obtained;Drug-treated cells were more blocked in the G1 phase.In drug-resistant cells,the expression of apoptosis suppressor gene Bcl-2 was significantly decreased and the apoptotic gene Bax as well as the drug-resistant genes were all significantly increased(P＜0.05).The LC3-Ⅱ/LC3-Ⅰ ratio of drug-resistant cells was significantly higher than that of parent cells(P＜0.05).Conclusions Sorafenib may block the cell cycle,suppress malignant cell proliferation and promote autophage.On one hand,autophagy participates in the development of cell drug resistance and promotes cell survival.On the other hand,drug-induced autophagy may activate some of apoptotic signaling pathway in drug-resistant cells and promote the reversal of cell drug resistance.